Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA)

33 filings reported holding SANA - Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share as of Q1 2024.
Sana Biotechnology, Inc. - Common Stock, par value $0.0001 per share (SANA) has 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 5.84M shares of 266M outstanding shares and own 2.19% of the company stock.
Largest 10 shareholders include CITADEL ADVISORS LLC (1.89M shares), MORGAN STANLEY (1.49M shares), JPMORGAN CHASE & CO (1.11M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (824K shares), DEUTSCHE BANK AG\ (435K shares), Bank of New York Mellon Corp (341K shares), NORGES BANK (250K shares), Legal & General Group Plc (108K shares), Erste Asset Management GmbH (40K shares), and Voya Investment Management LLC (31.9K shares).
This table shows the top 13 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.